HomeCompareAPEN vs YUM

APEN vs YUM: Dividend Comparison 2026

APEN yields 20.00% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $34.0K in total portfolio value· pulled ahead in Year 9
10 years
APEN
APEN
● Live price
20.00%
Share price
$10.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$73.0K
Annual income
$6,738.96
Full APEN calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — APEN vs YUM

📍 YUM pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPENYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APEN + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APEN pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APEN
Annual income on $10K today (after 15% tax)
$1,700.00/yr
After 10yr DRIP, annual income (after tax)
$5,728.12/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, YUM beats the other by $28,235.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APEN + YUM for your $10,000?

APEN: 50%YUM: 50%
100% YUM50/50100% APEN
Portfolio after 10yr
$90.0K
Annual income
$23,348.14/yr
Blended yield
25.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

APEN
Analyst Ratings
4
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$9.50
-5.0% upside vs current
Range: $9.00 — $10.00
Altman Z
0.7
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APEN buys
0
YUM buys
0
No recent congressional trades found for APEN or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPENYUM
Forward yield20.00%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$73.0K$107.0K
Annual income after 10y$6,738.96$39,957.33
Total dividends collected$41.5K$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$9.50$173.15

Year-by-year: APEN vs YUM ($10,000, DRIP)

YearAPEN PortfolioAPEN Income/yrYUM PortfolioYUM Income/yrGap
1$12,700$2,000.00$10,980$280.44+$1.7KAPEN
2$15,963$2,373.83$12,185$435.72+$3.8KAPEN
3$19,869$2,788.51$13,722$684.14+$6.1KAPEN
4$24,503$3,243.76$15,773$1,090.14+$8.7KAPEN
5$29,957$3,738.69$18,650$1,773.02+$11.3KAPEN
6$36,326$4,271.82$22,921$2,966.37+$13.4KAPEN
7$43,710$4,841.12$29,685$5,158.69+$14.0KAPEN
8$52,214$5,444.08$41,216$9,453.02+$11.0KAPEN
9← crossover$61,947$6,077.78$62,672$18,571.31$725.00YUM
10$73,022$6,738.96$107,016$39,957.33$34.0KYUM

APEN vs YUM: Complete Analysis 2026

APENStock

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Full APEN Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this APEN vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APEN vs SCHDAPEN vs JEPIAPEN vs OAPEN vs KOAPEN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.